Filter Results:
(5,799)
Show Results For
- All HBS Web
(5,799)
- People (19)
- News (2,242)
- Research (2,822)
- Events (3)
- Multimedia (224)
- Faculty Publications (1,978)
Show Results For
- All HBS Web
(5,799)
- People (19)
- News (2,242)
- Research (2,822)
- Events (3)
- Multimedia (224)
- Faculty Publications (1,978)
- February 2009 (Revised December 2009)
- Case
Merck: Global Health and Access to Medicines
By: V. Kasturi Rangan and Katharine Lee
The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its business strategy with its corporate social... View Details
Keywords: Globalized Firms and Management; Health Care and Treatment; Emerging Markets; Corporate Social Responsibility and Impact; Poverty; Business Strategy; Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Merck: Global Health and Access to Medicines." Harvard Business School Case 509-048, February 2009. (Revised December 2009.)
- 2014
- Working Paper
The Diseconomies of Queue Pooling: An Empirical Investigation of Emergency Department Length of Stay
By: Hummy Song, Anita L. Tucker and Karen L. Murrell
We conduct an empirical investigation of the impact of queue management on patients' average wait time and length of stay (LOS). Using an Emergency Department's (ED) patient-level data from 2007 to 2010, we find that patients' average wait time and LOS are longer when... View Details
Keywords: Pooling; Queue Management; Strategic Servers; Social Loafing; Empirical Operations; Health Care; Fairness; Management Practices and Processes; Service Delivery; Health Care and Treatment; Health Industry
Song, Hummy, Anita L. Tucker, and Karen L. Murrell. "The Diseconomies of Queue Pooling: An Empirical Investigation of Emergency Department Length of Stay." Working Paper. (October 2014.)
- January 2019
- Teaching Note
Pricing PatientPing
Teaching Note for HBS No. 818-017. PatientPing sells a software platform that allows health care providers to receive real-time notifications (“pings”) when one of their patients is admitted to or discharged from a health-care facility. The platform facilitates... View Details
- June 2014 (Revised April 2015)
- Supplement
OrthoChoice: Bundled Payments in the County of Stockholm (B)
By: Michael E. Porter, Clifford M. Marks and Zachary C. Landman
By the end of 2008, all major hospitals (one of which was private) and three private specialized orthopedic centers signed OrthoChoice contracts. In 2009, hip and knee replacements in the County of Stockholm for relatively healthy patients began being reimbursed. By... View Details
Keywords: Hip Replacement; Bundled Payment; Knee Replacement; Value Agenda; Strategy; Health Care Industry; Health; Health Care and Treatment; Health Disorders; Health Industry; Sweden
Porter, Michael E., Clifford M. Marks, and Zachary C. Landman. "OrthoChoice: Bundled Payments in the County of Stockholm (B)." Harvard Business School Supplement 714-515, June 2014. (Revised April 2015.)
- 24 Apr 2014
- News
Student turns family health crisis into online solution
When Shana Hoffman (MBA 2014) and her family tried to navigate the world of health care in the US to help Hoffman’s father with his medical issues, the electrical systems engineer looked at the problem from... View Details
- September 2010
- Teaching Note
Acumen Fund: Measurement in Impact Investing (TN) (A) and (B)
By: Alnoor Ebrahim
Teaching Note for 310011 and 310017. View Details
- November 2016
- Case
QuintilesIMS: Biosimilar Marketing in England
By: John A. Quelch and Emily C. Boudreau
QuintilesIMS was a leading healthcare consulting firm best known for its data and information offerings as well as its market research and management consulting services for life science companies. By 2015, the company was expanding beyond the biopharmaceutical... View Details
Keywords: Health; Pharmaceutical Industry; Biotech; Marketing; Health Care and Treatment; Biotechnology Industry; England
Quelch, John A., and Emily C. Boudreau. "QuintilesIMS: Biosimilar Marketing in England." Harvard Business School Case 517-054, November 2016.
- January 2017 (Revised March 2021)
- Case
Fitbit
By: Regina E. Herzlinger, Christine Snively and Sarah Mehta
In 2019, Fitbit lost its leadership in the wearable sensor market to Apple and to cheaper alternatives.
Why did it lose its market position?
How will the proposed acquisition affect it and Google? View Details
Why did it lose its market position?
How will the proposed acquisition affect it and Google? View Details
- June 2013
- Teaching Note
Boston Children's Hospital: Measuring Patient Costs
By: Robert S. Kaplan
- February 1, 2024
- Editorial
Retired Military Officials: Protecting Abortion Care Keeps America Safe
By: Louis Caldera, Ray Mabus and Deborah James
Caldera, Louis, Ray Mabus, and Deborah James. "Retired Military Officials: Protecting Abortion Care Keeps America Safe." Washingtonpost.com (February 1, 2024).
- June 2024
- Article
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices
By: Jason Shafrin, Jaehong Kim, Joshua T. Cohen, Louis P. Garrison, Dana A. Goldman, Jalpa A. Doshi, Joshua Krieger, Darius N. Lakdawalla, Peter J. Neumann, Charles E. Phelps, Melanie D. Whittington and Richard Willke
This study argues that value assessment conducted from a societal perspective should rely on the Generalized Cost-Effectiveness Analysis (GCEA) framework proposed herein. Recently developed value assessment inventories—such as the Second Panel on Cost-Effectiveness’s... View Details
Shafrin, Jason, Jaehong Kim, Joshua T. Cohen, Louis P. Garrison, Dana A. Goldman, Jalpa A. Doshi, Joshua Krieger, Darius N. Lakdawalla, Peter J. Neumann, Charles E. Phelps, Melanie D. Whittington, and Richard Willke. "Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices." Forum of Health Economics and Policy 27, no. 1 (June 2024): 29–116.
- 01 Apr 2001
- News
Big Deals: Project Finance Helps Mitigate Risk in Large-Scale Investments
cost something on the order of $5 billion, not the $5 million one might expect for a typical start-up,” Esty explains. And all too often, he adds, they can turn out to be losing propositions. The managerial challenge is to make sure that $150 billion or so of annual... View Details
Keywords: Julia Hanna; Motorola; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments; Securities, Commodities, and Other Financial Investments
- August 2022
- Supplement
Sweet Teez Bakery: Projecting the Dough’s Rise Financial Supplement
By: Emily R. McComb, Mel Martin and Amy Klopfenstein
Abstract: In 2021, the HBS Impact Investment Fund student team met with entrepreneur Teresa Maynard, who had applied for a $25,000 impact investment loan. The students thought the former Harvard Data Scientist’s bakery business, Sweet Teez Bakery, showed promise.... View Details
- 06 Aug 2020
- Blog Post
My HBS Financial Aid Story: Why I Chose to Invest in My Future
Everyone I spoke to told me the same thing: “Think of it as an investment in yourself.” Reframing the cost of attendance to view it as an investment was a game-changer for me. I used various lender-provided... View Details
- 04 Dec 2013
- Research & Ideas
The Fantastic Horizon: How to Invest in a New City
and Syria; to the south is the booming Saudi Arabian metropolis of Jeddah. In front of me is a vast expanse of sand and hope, fueled by a huge investment towards a brand new city the size of Washington, DC. I can see intermittent puffs... View Details
- 12 Oct 2015
- News
Google Ventures: Big-time Consumer Health Is Still a Dream
- March 2014 (Revised December 2014)
- Case
Vision 2020: Takeda and the Vaccine Business
By: John A. Quelch and Margaret L. Rodriguez
In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003... View Details
Keywords: Health Care; Global; NGO; Public Health; Japan; GSK; Vaccine; Supply Chain; Market Entry; Health; Health Care and Treatment; Trade; Market Entry and Exit; Global Strategy; Health Industry; Health Industry
Quelch, John A., and Margaret L. Rodriguez. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Case 514-084, March 2014. (Revised December 2014.)
- May 1996
- Teaching Note
Partners HealthCare System, Inc. (B): Cardiac Care Improvement TN
By: Gary P. Pisano
Teaching Note for (9-696-063). View Details
- 09 Nov 2023
- HBS Case
What Will It Take to Confront the Invisible Mental Health Crisis in Business?
health research fund after his son experienced a psychotic break. In the following interview, Cohen, the L.E. Simmons Professor of Business Administration at HBS, discusses why it’s important for organizations to address mental View Details